Recall Z-0285-2018
Randox Laboratories Ltd. · initiated June 7, 2017
Class II – products that might cause a temporary health problem or pose a slight threat of a serious nature
Product
Rx series HbA1c REF/Catalog Number HA3830, GTIN 05055273203561, IVD; -- RANDOX LABORATORIES LTD. , This product is suitable for use on RX series instruments which includes the RX Daytona and RX Imola analysers. Packaging Format: HbA1c R1: Antibody Reagent - 3 x 14 ml HbA1c R2: Agglutinator Reagent - 3 x 14 ml R3: Haemoglobin Denaturant Reagent - 3 x 50 ml Hb R1: Total Haemoglobin Reagent - 3 x 28 ml For Professional Use in the quantitative in vitro determination of Haemoglobin A1c concentration in whole blood.
Codes / lots: Lot/Batch 414553, expiry 28th Jan 2019
Reason for recall
Randox confirmed low calibration absorbance with HbA1c, Catalog Number HA3830, Batch 414553. The reagent may not continue to meet its specific performance characteristics throughout the shelf life of the product.
FDA-determined cause: Under Investigation by firm
Action taken
Randox Laboratories sent an Urgent Field Safety Notice dated June 6, 2017, sent to all global consignees on June 7, 2017, via e-mail. This includes the sole US consignee. Customers are advised to dispose of any existing stock and to contact technical support with respect to reimbursement for loss of material. The company will follow up every 2 weeks over a six week period with the consignees. For further questions, please call (304) 728-2890.
Details
- Recall number
- Z-0285-2018
- Initiated
- June 7, 2017
- Terminated
- July 2, 2018
- Product code
- LCP – Assay, Glycosylated Hemoglobin
- Quantity
- 90 kits
- Distribution
- Puerto Rico; International: Portugal, Italy, Turkey, Slovakia, Russia, Thailand and Vietnam
- Recalling firm
- Randox Laboratories Ltd., Crumlin, North